Single-cell transcriptomics of chimeric antigen receptor (CAR) T cell infusion products
Ontology highlight
ABSTRACT: Adoptive immunotherapy with T cells expressing chimeric antigen receptors (CARs) for B-cell malignancies serves as a model for identifying subsets with superior clinical activity. We profiled the infusion products (IP) of 9 patients with large B-cell lymphoma (LBCL) using scRNA-sequencing to reveal the therapeutic potential of CD19-specific CAR+ T cells. ScRNA-seq demonstrated that T cells from responders were enriched in pathways related to T-cell killing, migration and actin cytoskeleton, and TCR clustering.
ORGANISM(S): Homo sapiens
PROVIDER: GSE208052 | GEO | 2023/03/12
REPOSITORIES: GEO
ACCESS DATA